Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 15.04 USD 0.8% Market Closed
Market Cap: 610.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-2%
Revenue
Forecast
+14%
Operating Income
Forecast
+27%
Net Income
Forecast
+1%

Wall Street
Price Targets

RXST Price Targets Summary
Rxsight Inc

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 22.03 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

RXST Lowest Forecast
Wall Street Target
16.16 USD
7% Upside
RXST Average Forecast
Wall Street Target
22.03 USD
46% Upside
RXST Highest Forecast
Wall Street Target
29.4 USD
95% Upside
Lowest
Price Target
16.16 USD
7% Upside
Average
Price Target
22.03 USD
46% Upside
Highest
Price Target
29.4 USD
95% Upside
Rxsight Inc Competitors:
Price Targets
G
GENT
Gentian Diagnostics ASA
12% Upside
FIGS
Figs Inc
9% Downside
NAN
Nanosonics Ltd
16% Upside
MED
Medartis Holding AG
21% Upside
G
GENT
Gentian Diagnostics ASA
12% Upside
FIGS
Figs Inc
9% Downside
NAN
Nanosonics Ltd
16% Upside
MED
Medartis Holding AG
21% Upside
300888
Winner Medical Co Ltd
20% Upside
300981
Zhonghong Pulin Medical Products Co Ltd
8% Downside
7741
Hoya Corp
35% Upside
ICUI
ICU Medical Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Rxsight Inc

For the last 4 years the compound annual growth rate for Rxsight Inc's revenue is 76%. The projected CAGR for the next 3 years is 21%.

76%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
RXST intrinsic value, competitors valuation, and company profile.
DCF Valuation
RXST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RXST stock valuation using valuation multiples.
Wall Street Estimates
RXST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RXST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXST's stock price target?
Price Target
22.03 USD

According to Wall Street analysts, the average 1-year price target for RXST is 22.03 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

What is Rxsight Inc's Revenue forecast?
Projected CAGR
21%

For the last 4 years the compound annual growth rate for Rxsight Inc's revenue is 76%. The projected CAGR for the next 3 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.